The Weight Loss Duopoly Faces a Chemical Rebellion
The needle is dyingPatients hate the sting. Investors hate the churn. For two years, Eli Lilly and Novo Nordisk have…
The needle is dyingPatients hate the sting. Investors hate the churn. For two years, Eli Lilly and Novo Nordisk have…
The metabolic gold rush is hitting a wall. Patients are tired of the needles. They are tired of the nausea.…
The Financial Physics of Hillside EngineeringThe crane count in Austin is lying to you. It suggests a city in perpetual,…
The math does not work. Yesterday, the World Economic Forum suggested that artificial intelligence is the primary lever for scaling…
The ticker flashed red. Dajin Heavy Industry met a wall of indifference. The Friday debut of the wind power equipment…
The Mobility Crisis at the GateLabor is the friction. Automation is the lubricant. The cost of human-led wheelchair assistance has…
The Davos Pivot to Data IntegrityThe Davos crowd is nervous. This morning, the World Economic Forum signaled a shift in…
The wings held. The cash flowed. Boeing is back.Two years ago, the manufacturer was a corporate pariah. It was a…
The Sky Burned Capital evaporated in the Florida heat last Thursday. Blue Origin’s New Glenn, the heavy-lift cornerstone of Jeff…
The asphalt is losing. Silicon is winning. For the first time in modern economic history, private capital expenditure on data…